ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,994.57
-0.76%
US Tech 100
20,870.80
-0.10%
Dow Jones
44,421.91
-0.28%
Brent Oil
75.315
-0.06%
Bitcoin
100,259.45
-1.14%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Hemogenyx Pharmaceuticals Plc (HEMO)

  7. Hemogenyx Pharmaceuticals Plc (HEMO) News

HEMO

Hemogenyx Pharmaceuticals (HEMO)

Hemogenyx Pharmaceuticals Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:HEMO
DateTimeSourceHeadlineSymbolCompany
01/31/20254:35AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
01/08/20256:49AMAlliance NewsAlliance NewsIN BRIEF: Hemogenyx Pharmaceuticals raises GBP340,000 for drug trialLSE:HEMOHemogenyx Pharmaceuticals Plc
01/08/20252:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Placing to raise £340,000LSE:HEMOHemogenyx Pharmaceuticals Plc
01/02/20252:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Change of Company Secretary and Registered OfficeLSE:HEMOHemogenyx Pharmaceuticals Plc
12/31/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
12/30/20247:01AMAlliance NewsAlliance NewsHemogenyx opens first clinical site for leukaemia therapy trialLSE:HEMOHemogenyx Pharmaceuticals Plc
12/30/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Opening of First Clinical SiteLSE:HEMOHemogenyx Pharmaceuticals Plc
12/19/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Ultrafast CAR-T ManufacturingLSE:HEMOHemogenyx Pharmaceuticals Plc
12/10/202411:10AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Admission of New Ordinary Shares and New ISINLSE:HEMOHemogenyx Pharmaceuticals Plc
12/09/20248:30AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Result of Extraordinary General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
12/09/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Site Initiation Visit CompletedLSE:HEMOHemogenyx Pharmaceuticals Plc
12/06/202410:40AMAlliance NewsAlliance NewsTRADING UPDATES: SDX plots AIM exit; Celadon receives fundsLSE:HEMOHemogenyx Pharmaceuticals Plc
12/06/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC CBR Macrophage Delivery UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
11/29/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Total Voting RightsLSE:HEMOHemogenyx Pharmaceuticals Plc
11/22/20247:49AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Notice of Extraordinary General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
11/22/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC IRB Approval for Phase I Clinical TrialLSE:HEMOHemogenyx Pharmaceuticals Plc
11/11/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Institutional InvestmentLSE:HEMOHemogenyx Pharmaceuticals Plc
10/30/20247:09AMAlliance NewsAlliance NewsIN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trialLSE:HEMOHemogenyx Pharmaceuticals Plc
10/30/20243:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Schedule for Phase I Clinical Trial OpeningLSE:HEMOHemogenyx Pharmaceuticals Plc
10/02/20246:19AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Strategic Investment from Prevail Partners, LLCLSE:HEMOHemogenyx Pharmaceuticals Plc
09/27/20241:25PMAlliance NewsAlliance NewsHemogenyx Pharmaceuticals loss narrows amid reduced expensesLSE:HEMOHemogenyx Pharmaceuticals Plc
09/27/202410:55AMAlliance NewsAlliance NewsEARNINGS: Clean Power Hydrogen loss widens; Invinity loss narrowsLSE:HEMOHemogenyx Pharmaceuticals Plc
09/27/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Half-year ReportLSE:HEMOHemogenyx Pharmaceuticals Plc
09/09/20245:03PMAlliance NewsAlliance NewsTRADING UPDATES: Light Science Technologies wins two new contractsLSE:HEMOHemogenyx Pharmaceuticals Plc
09/09/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC FLT3 Assay Ready for Phase I Trials at MD AndersonLSE:HEMOHemogenyx Pharmaceuticals Plc
09/02/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC CDX Development UpdateLSE:HEMOHemogenyx Pharmaceuticals Plc
08/28/20242:00AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Presentation at CBD S&T ConferenceLSE:HEMOHemogenyx Pharmaceuticals Plc
07/29/20242:00AMRNS Non-RegulatoryHemogenyx Pharmaceuticals PLC Macrophage-Directed Therapies Summit PresentationLSE:HEMOHemogenyx Pharmaceuticals Plc
06/27/202411:39AMRNS Regulatory NewsHemogenyx Pharmaceuticals PLC Result of Annual General MeetingLSE:HEMOHemogenyx Pharmaceuticals Plc
06/17/20242:55PMAlliance NewsAlliance NewsIN BRIEF: Hemogenyx Pharmaceuticals updates on leukemia treatmentLSE:HEMOHemogenyx Pharmaceuticals Plc
 Showing the most relevant articles for your search:LSE:HEMO

Your Recent History

USOTC
MGON
Megola (PK)
NASDAQ
SMCI
Super Micro Computer
USOTC
AFFU
Affluence (PK)
COIN
XRPUSD
Ripple
USOTC
LQMT
Liquidmetal Technologies (QB)
USOTC
IQST
iQSTEL (QX)
USOTC
RITE
MineralRite (PK)
USOTC
HMBL
HUMBL (PK)
USOTC
RDGL
Vivos (QB)
USOTC
TPTW
TPT Global Tech (CE)
NASDAQ
NB
NioCorp Developments
NASDAQ
TSLA
Tesla
NASDAQ
TNXP
Tonix Pharmaceuticals
USOTC
AABB
Asia Broadband (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
RNVA
Rennova Health (CE)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads